In addition to a high rate of deaths, ADC Therapeutics’ Zynlonta plus rituximab showed no overall survival benefit in ...
Three times as many deaths in the study arm versus the control arm in a trial of ADC Therapeutics' Zynlonta have raised ...
ADC Therapeutics weighs ZYNLONTA safety risks in its LOTIS-5 trial against strategic cost alternatives. Read why ADCT stock ...
The Governorship Candidate of the African Democratic Congress (ADC) in Sokoto State, Manir Muhammad Dan’iya (Walin Sokoto), ...
Shares for ADC Therapeutics fell more than 50% after a Phase 3 trial observed a death rate that at least one analyst believes ...
A chieftain of the African Democratic Congress (ADC) in Nasarawa State, Comrade Abdullahi Ibrahim Ismael, has raised alarm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results